Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Werdan

Showing results (111-120 of 249) with videos related to

Pageof 25
Sort By:
Cardiovascular Research|July 17, 2008
E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivoHenning Ebelt, Ying Zhang, Alexander Kampke, et al.
Human Mutation|October 29, 2002
The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis--novel genomic variants and functional consequencesSusanne Schulz, Undraga Schagdarsurengin, Petra Greiser, et al.
Artificial Organs|May 22, 2012
Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidenceMichael Buerke, Roland Prondzinsky, Henning Lemm, et al.
Canadian Journal of Physiology and Pharmacology|April 17, 2009
Impaired regulation of cardiac function in sepsis, SIRS, and MODSKarl Werdan, Hendrik Schmidt, Henning Ebelt, et al.
The Cochrane Database of Systematic Reviews|January 30, 2018
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndromeJulia Schumann, Eva C Henrich, Hellen Strobl, et al.
Circulation Research|February 19, 2005
Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosisHenning Ebelt, Nadine Hufnagel, Petra Neuhaus, et al.
Deutsches Arzteblatt International|April 16, 2026
Assessment of Indications for Percutaneous Coronary Intervention: A Multicenter Analysis after the Diagnosis of Chronic Coronary SyndromeUwe Zeymer, Natalia Kelsch, Karl Werdan, et al.
BMC Cardiovascular Disorders|November 15, 2005
Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) StudyKarin H Greiser, Alexander Kluttig, Barbara Schumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2025
LipidSnapshot - Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented by office-based cardiologists and general practitioners in GermanyOliver Weingärtner, Simon Glück, Karl Werdan, et al.
Cytokine|September 1, 2016
C-reactive protein levels and genetic variants of CRP as prognostic markers for combined cardiovascular endpoint (cardiovascular death, death from stroke, myocardial infarction, and stroke/TIA)Susanne Schulz, Henriette Lüdike, Madlen Lierath, et al.
Pageof 25

Showing results (111-120 of 249) with videos related to

Sort By:
Pageof 25
Cardiovascular Research|July 17, 2008
E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivoHenning Ebelt, Ying Zhang, Alexander Kampke, et al.
Human Mutation|October 29, 2002
The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis--novel genomic variants and functional consequencesSusanne Schulz, Undraga Schagdarsurengin, Petra Greiser, et al.
Artificial Organs|May 22, 2012
Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidenceMichael Buerke, Roland Prondzinsky, Henning Lemm, et al.
Canadian Journal of Physiology and Pharmacology|April 17, 2009
Impaired regulation of cardiac function in sepsis, SIRS, and MODSKarl Werdan, Hendrik Schmidt, Henning Ebelt, et al.
The Cochrane Database of Systematic Reviews|January 30, 2018
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndromeJulia Schumann, Eva C Henrich, Hellen Strobl, et al.
Circulation Research|February 19, 2005
Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosisHenning Ebelt, Nadine Hufnagel, Petra Neuhaus, et al.
Deutsches Arzteblatt International|April 16, 2026
Assessment of Indications for Percutaneous Coronary Intervention: A Multicenter Analysis after the Diagnosis of Chronic Coronary SyndromeUwe Zeymer, Natalia Kelsch, Karl Werdan, et al.
BMC Cardiovascular Disorders|November 15, 2005
Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) StudyKarin H Greiser, Alexander Kluttig, Barbara Schumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2025
LipidSnapshot - Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented by office-based cardiologists and general practitioners in GermanyOliver Weingärtner, Simon Glück, Karl Werdan, et al.
Cytokine|September 1, 2016
C-reactive protein levels and genetic variants of CRP as prognostic markers for combined cardiovascular endpoint (cardiovascular death, death from stroke, myocardial infarction, and stroke/TIA)Susanne Schulz, Henriette Lüdike, Madlen Lierath, et al.
Pageof 25